Laurent-Puig P - Search Results

1

6-mercaptopurine promotes energetic failure in proliferating T cells.

Fernández-Ramos AA, Marchetti-Laurent C, Poindessous V, Antonio S, Laurent-Puig P, Bortoli S, Loriot MA, Pallet N. Fernández-Ramos AA, et al. Oncotarget. 2017 Jun 27;8(26):43048-43060. doi: 10.18632/oncotarget.17889. Oncotarget. 2017. PMID: 28574837 Free PMC article.

2

Myeloperoxidase: new polymorphisms and relation with lung cancer risk.

Chevrier I, Stücker I, Houllier AM, Cenée S, Beaune P, Laurent-Puig P, Loriot MA. Chevrier I, et al. Pharmacogenetics. 2003 Dec;13(12):729-39. doi: 10.1097/01.fpc.0000054143.14659.ba. Pharmacogenetics. 2003. PMID: 14646692

3

Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.

Ferraz JM, Zinzindohoué F, Lecomte T, Cugnenc PH, Loriot MA, Beaune P, Stücker I, Berger A, Laurent-Puig P. Ferraz JM, et al. Int J Cancer. 2004 Jun 10;110(2):183-7. doi: 10.1002/ijc.20124. Int J Cancer. 2004. PMID: 15069679

4

Pharmacogenetics of acenocoumarol pharmacodynamics.

Morin S, Bodin L, Loriot MA, Thijssen HH, Robert A, Strabach S, Verstuyft C, Tregouet DA, Dubert L, Laurent-Puig P, Funck-Brentano C, Jaillon P, Beaune PH, Becquemont L. Morin S, et al. Clin Pharmacol Ther. 2004 May;75(5):403-14. doi: 10.1016/j.clpt.2004.01.008. Clin Pharmacol Ther. 2004. PMID: 15116053

5

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P. Zinzindohoué F, et al. Anticancer Res. 2004 May-Jun;24(3b):2021-6. Anticancer Res. 2004. PMID: 15274394 Free article.

6

Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.

Lecomte T, Ferraz JM, Zinzindohoué F, Loriot MA, Tregouet DA, Landi B, Berger A, Cugnenc PH, Jian R, Beaune P, Laurent-Puig P. Lecomte T, et al. Clin Cancer Res. 2004 Sep 1;10(17):5880-8. doi: 10.1158/1078-0432.CCR-04-0169. Clin Cancer Res. 2004. PMID: 15355920

7

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

Bodin L, Verstuyft C, Tregouet DA, Robert A, Dubert L, Funck-Brentano C, Jaillon P, Beaune P, Laurent-Puig P, Becquemont L, Loriot MA. Bodin L, et al. Blood. 2005 Jul 1;106(1):135-40. doi: 10.1182/blood-2005-01-0341. Epub 2005 Mar 24. Blood. 2005. PMID: 15790782 Free article. Clinical Trial.

8

Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.

Lecomte T, Landi B, Beaune P, Laurent-Puig P, Loriot MA. Lecomte T, et al. Clin Cancer Res. 2006 May 15;12(10):3050-6. doi: 10.1158/1078-0432.CCR-05-2076. Clin Cancer Res. 2006. PMID: 16707601

9

Hepatocellular carcinoma and occupation in men: a case-control study.

Ferrand JF, Cénée S, Laurent-Puig P, Loriot MA, Trinchet JC, Degos F, Bronovicky JP, Pelletier G, Stücker I. Ferrand JF, et al. J Occup Environ Med. 2008 Feb;50(2):212-20. doi: 10.1097/JOM.0b013e31815d88e2. J Occup Environ Med. 2008. PMID: 18301178

10

[The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].

Laurent-Puig P, Lièvre A, Ducreux M, Loriot MA. Laurent-Puig P, et al. Bull Cancer. 2008 Oct;95(10):935-42. doi: 10.1684/bdc.2008.0728. Bull Cancer. 2008. PMID: 19004723 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters